Loading organizations...
Green Bioactives, based in Penicuik, Scotland, United Kingdom, developed a sustainable plant cell-based biomanufacturing platform to produce high-value bioactive compounds from plant stem cells for use in cosmetics, pharmaceuticals, food, agriculture, and health industries. The company's process involved cultivating plant stem cells and scaling production in bioreactors to extract beneficial compounds, such as those for memory support and skincare, launching products like GBL-Memory. Despite developing product readiness, the organization entered liquidation in September 2025 after a failed funding round. It had raised $4.19 million in total funding and operated with under 25 employees. Key personnel included Chair Thomas Nagy, CSO Andy Hall-Ponselè, and CBO Chris Meaney, with biomanufacturing consultant John Stevenson engaged for production scale-up. Green Bioactives was founded in 2018 by Gary Loake.
Green Bioactives has raised $3.2M across 1 funding round.
Green Bioactives has raised $3.2M in total across 1 funding round.
Green Bioactives has raised $3.2M across 1 funding round. Most recently, it raised $3.2M Seed in December 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Dec 13, 2022 | $3.2M Seed | Andrew Durkie | Milltrust Ventures, Regenerate Ventures, Scottish Enterprise | Announced |
Green Bioactives has raised $3.2M in total across 1 funding round.
Green Bioactives's investors include Andrew Durkie, Milltrust Ventures, Regenerate Ventures, Scottish Enterprise.
